首页> 外文期刊>Perspectives in vascular surgery and endovascular therapy. >Commentary on 'Carotid artery disease: selecting the appropriate asymptomatic patient for intervention'.
【24h】

Commentary on 'Carotid artery disease: selecting the appropriate asymptomatic patient for intervention'.

机译:关于“颈动脉疾病:选择合适的无症状患者进行干预”的评论。

获取原文
获取原文并翻译 | 示例
           

摘要

Intervention in patients with asymptomatic carotid artery disease has been debated back and forth by neurologists, vascular surgeons, neurosurgeons, and interventionalists for the past 20 years.In their article, Drs Rockman and Riles reiterate the numerous prospective randomized trials that have unequivocally demonstrated the benefit and durability of endarter-ectomy in the treatment of symptomatic and asymptomatic extracranial carotid artery atherosclerosis. These studies help clinicians present logical plans to those patients who present with asymptomatic hemodynamically significant bifurcation disease. The goal of this operation is solely to prevent stroke and preserve neurologic function. The most important caveat derived from ACAS and NASCET was a benchmark to give patients realistic outcomes in order for us to offer patients a reasonable, safe, and durable plan that protects them from stroke, be it medical, surgical, or endovascular.
机译:在过去的20年中,神经科医师,血管外科医师,神经外科医师和介入医师一直在反复讨论无症状性颈动脉疾病患者的干预.Rockman和Riles博士在其文章中重申了许多前瞻性随机试验,这些试验明确地证明了其益处内膜切除术在有症状和无症状颅外颈动脉粥样硬化治疗中的作用和持久性。这些研究帮助临床医生为那些表现出无症状的血液动力学上明显分叉疾病的患者提出合理的计划。该手术的目的仅是预防中风并保持神经功能。来自ACAS和NASCET的最重要警告是为患者提供现实结果的基准,以便我们为患者提供合理,安全和持久的计划,以保护他们免受中风的侵害,无论是医疗,手术还是血管内治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号